環球醫療(02666.HK)擬委任信永中和爲公司核數師
格隆匯5月6日丨環球醫療(02666.HK)宣佈,經考慮安永已連續擔任公司核數師超過十年,公司在綜合考慮業務發展、成本效益及審計服務需求後,啓動了核數師公開採購選聘程序。根據公開採購選聘結果及經董事會審覈委員會(「審覈委員會」)推薦,安永將於公司將於2025年5月28日舉行的應屆股東周年大會結束時起退任公司核數師。
董事會進一步宣佈,根據公開採購選聘結果及經審覈委員會推薦,董事會已決議建議委任信永中和(香港)會計師事務所有限公司("信永中和")爲公司核數師,任期自股東周年大會結束後開始及直至公司下屆股東周年大會結束爲止,惟須獲股東於股東周年大會上批準。建議委任信永中和將於股東周年大會上以普通決議案方式提呈股東批準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.